Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Johnson & Johnson (NYSE:JNJ) has long been considered one of the most dependable dividend stocks, ...

This week's dividend activity included increased payouts from Citigroup (NYSE:C) and Duke Energy (DUK) as well as ...

The United States market has been flat over the last week but is up 14% over the past year, with earnings forecast to grow by 15% annually. In this environment, dividend stocks can offer a reliable ...

J&J's diversified business, robust pipeline, and strong free cash flow provide stability, despite legal challenges. Read more ...

Key Points Johnson & Johnson continues to generate plenty of free cash flow to cover its dividend. The healthcare giant also ...

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

ExxonMobil has the best dividend growth track record in the oil industry. Johnson & Johnson has increased its dividend for ...

Live Updates Live Coverage Updates appear automatically as they are published. Johnson & Johnson Beats 7:31 am by Eric Bleeker Johnson & Johnson delivered EPS of $2.77, which tops estimates of $2.68.

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Shares of Johnson & Johnson climbed 4.5% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for the biggest one-day gain since they rallied 4.6% on May 1, 2024.

Earnings season is officially here, and it’s off to a strong start. Goldman Sachs (GS), Bank of America (BAC), and Johnson & Johnson (JNJ) all topped EPS estimates, while Morgan Stanley (MS) added a ...

Johnson & Johnson's stock rose 2.4% in premarket trading, enough to pace the Dow Jones Industrial Average's DJIA early gainers. Shares of rival Pfizer Inc. (PFE) were up 0.3% in premarket trades and ...